Back to Top
Go Back
Journal Photo for Cancer Investigation
Peer reviewed only Open Access

Cancer Investigation (JSN)

Publisher : Taylor & Francis
Cancer Investigation Clinical studies precision oncology
Claim Your Journal Get PRC Visit Website
e-ISSN 1532-4192
p-ISSN 0735-7907
Issue Frequency 10-issues-year
Impact Factor 1.8
Est. Year 2025
Mobile 4402080520500
DOI YES
Country United Kingdom
Language English
APC YES
Impact Factor Assignee google scholar
Email enquiries@taylorandfrancis.com

Journal Descriptions

Cancer Investigation is a well-established, international journal publishing research on all aspects of oncology. Disseminating research for more than four decades, the journal aims to provide researchers and clinicians with a comprehensive resource on the current state of progress in the field of oncology, as well as a broad background of reliable information necessary for effective decision-making. Cancer Investigation provides a unique, nimble, cutting-edge publishing platform for a broad range of topics spanning the spectrum of oncology and the rapidly changing landscape of oncology.

Cancer Investigation (JSN) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Cancer Investigation, Clinical studies, precision oncology, genomic medicine, novel technologies, Art of Medicine, letters to the editor , Online or Print , 10-issues-year Journal

  • UGC Approved, ISSN Approved: P-ISSN P-ISSN: 0735-7907, E-ISSN: 1532-4192, Established: 2025, Impact Factor: 1.8
  • Provides Crossref DOI

  • Indexed in: Scopus, WoS

  • Not indexed in DOAJ, PubMed, UGC CARE

Indexing

Publications of JSN

The Pittsburgh Sleep Quality Index (PSQI) Applied to Cancer Patients: Psychometric Properties and Factors Affecting Sleep Quality
Andreas Hinz January, 2025
Objective Cancer patients frequently report sleep problems. The Pittsburgh Sleep Quality Index (PSQI) is a 19-item instrument for assessing sleep problems. The main objective of this study ...
Weather-Related Factors and Patient-Reported Outcomes (PROs) in Cancer Patients: Results from the ExPRO Study
Hanna Salm January, 2025
Objective The ExPRO (External factors influencing patient reported outcomes of patients with malignant diseases) study explored associations between QoL data and environmental factors on th...
LDHB Mediates Histone Lactylation to Activate PD-L1 and Promote Ovarian Cancer Immune Escape
Xuemei Hu November, 2025
Background To investigate the effects of LDHB on lactylation of programmed cell death 1 ligand (PD-L1) and immune evasion of ovarian cancer. Methods Ovarian cancer cells were transfecte...
Gustative Roussy Immune Score is a Predictor for Major Pathological Response in Rectal Cancer: A Result from the Preoperative Intraarterial Chemoembol...
Xiaochen WU July, 2024
Despite the emergence of various treatment strategies for rectal cancer based on neoadjuvant chemoradiotherapy, there is currently a lack of reliable biomarkers to determine which patients w...
Barthel Index and Age as Predictors of Discharge Destination in Patients with Glioblastoma
Hirotomo Shibahashi June, 2024
This study aimed to investigate the predictive factors of transfer of glioblastoma multiforme (GBM) patients who underwent rehabilitation in acute care hospitals. We retrospectively identifi...
A Bioinformatic Analysis of Gut Microbiota Related with Immune Cell Infiltration in Colorectal Cancer
Shengfen Zhang June, 2024
Objective The composition of microbiota which correlates with infiltrating immune cells and clinical signatures is not clarified in CRC. Methods We applied 4 kinds of bioinformatic tool...
Analytical and Clinical Validation of a Target-Enhanced Whole Genome Sequencing-Based Comprehensive Genomic Profiling Test
Erin Connolly-Strong May, 2024
Evaluation of the test performance of the Target enhanced whole-genome sequencing (TE-WGS) assay for comprehensive oncology genomic profiling. The analytical validation of the assay included...
Identifying Optimal Candidates for Primary Tumor Resection Among Metastatic Pancreatic Cancer Patients: A Population-Based Predictive Model
Kaifeng Su May, 2024
Background There is a controversy about whether surgery should proceed among metastatic pancreatic cancer (mPC) patients. A survival benefit was observed in mPC patients who underwent prima...
A 15-Inflammation-Related Gene Signature Predicts the Prognosis of Patients With Pancreatic Ductal Adenocarcinoma
Xiangyu Zhao April, 2024
Chronic inflammation promotes the development of pancreatic ductal adenocarcinoma (PDAC) and PDAC-related inflammatory tumor microenvironment facilitates tumor growth and metastasis. Thus, w...
Single Nucleotide Polymorphisms Associated with Prostate Cancer Progression: A Systematic Review
Martha Lucía December, 2023
Background New biomarkers of progression in patients with prostate cancer (PCa) are needed to improve their classification and clinical management. This systematic review investigated the r...